HAPILA and Transo-Pharm together at CPHI Frankfurt 2022 - booth 110D20

HAPILA and their distribution partner Transo-Pharm Handels GmbH have joined forces years ago in order to provide Estriol to more and more customers with high quality Estriol made in Germany.
 
The collaboration entered into a new phase when we decided to expand capacity at the Hapila site in order to adequately supply the Estriol market.
 
Consequently we made the decision to join forces at the CPhI Exhibition in Frankfurt and to integrate Hapila into the Transo-Pharm booth.
 
A few recent updates on Estriol:

• Capacity expansion program is well underway and we expect additional volumes to be available at the end of quarter I or beginning of quarter II 2023.
• In the meantime the CEP was updated to extend the retest period to 60 months

 
Looking forward to see you at CPHI in Frankfurt.